Moderna Stock Gains on Encouraging Flu Vaccine Data

• click to rate

  Posted by Two Blokes Jul 1 - Filed in Stock - 2 views
  
  MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.